RET and cancer: Nonetheless, these insights pave the way for further investigations into RET gain-of-function activation under disease conditions and potentially for the discovery of cancer therapies targeting the extracellular domain of RETC634R as well as the other dimerization-inducing oncogenic cysteine mutations.